Cargando…
Autologous hematopoietic stem cell transplant for autoimmune diseases: evolution,evidence of efficacy, and real-world economics
Despite an increase in the development of biological therapies for autoimmune disease (AID), a proportion of patients remain treatment refractory, resulting in long term morbidity and increased rates of mortality. Furthermore, maintenance biologic therapies are associated with treatment-related side...
Autores principales: | Massey, Jennifer C., Moore, John J., Milliken, Samuel T., Ma, David D. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asia-Pacific Blood and Marrow Transplantation Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599833/ https://www.ncbi.nlm.nih.gov/pubmed/37885825 http://dx.doi.org/10.31547/bct-2018-009 |
Ejemplares similares
-
Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant
por: Massey, Jennifer C., et al.
Publicado: (2018) -
Real-world application of autologous hematopoietic stem cell transplantation in 507 patients with multiple sclerosis
por: Burt, Richard K., et al.
Publicado: (2021) -
Membranous nephropathy in autologous hematopoietic stem cell transplant: autologous graft-versus-host disease or autoimmunity induction?
por: Abudayyeh, Ala, et al.
Publicado: (2015) -
Resetting the T Cell Compartment in Autoimmune Diseases With Autologous Hematopoietic Stem Cell Transplantation: An Update
por: Lutter, Lisanne, et al.
Publicado: (2018) -
Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: From Mechanistic Insights to Biomarkers
por: Malmegrim, Kelen Cristina Ribeiro, et al.
Publicado: (2018)